STAVE- SAXAGLIPTIN TRIAL TO ASSESS VASCULAR ENDPOINTS IN DIABETES MELLITUS
associated with 4424 other trademarks
Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use

Words that describe this trademark:

medical scientific research  conducting clinical trials  scientific research  clinical studies  research conducting  trials clinical  pharmaceutical preparations  clinical trials  relating  studies 

Serial Number:

77802485

Mark:

STAVE- SAXAGLIPTIN TRIAL TO ASSESS VASCULAR ENDPOINTS IN DIABETES MELLITUS

Status:

Abandoned-No Statement of Use filed

Status Date:

09-12-2011

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use

Mark Description:

N/A

Class:

Scientific and technological services

Type of Mark:

Servicemark

Published for Opposition Date:

06-15-2010

Mark Drawing Status:

Standart Character Mark

Abandon Date:

09-12-2011

Business Name:

BRISTOL-MYERS SQUIBB COMPANY

Correspondent Name:

Recent Trademark filings by this company